Cut-off Value of HSPG for Early Marker of Plasma Leakage in Adult Dengue Patient

Authors

  • Settrin Chenderawasi Community-Based Dengue Study, Faculty of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital, Jakarta
  • Rahajuningsih Dharma Department of Clinical Pathology, University of Indonesia, Jakarta
  • Herdiman T. Pohan Department of Internal Medicine, University of Indonesia, Jakarta
  • Beti Ernawati Dewi Community-Based Dengue Study, Faculty of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital, Jakarta/Department of Microbiology, University of Indonesia, Jakarta
  • Rianto Setiabudy Department of Pharmacology, University of Indonesia, Jakarta
  • Suhendro Suhendro Department of Internal Medicine, University of Indonesia, Jakarta
  • Aryati Aryati Department of Clinical Pathology, Airlangga University, Surabaya
  • Hardi Darmawan Department of Physiology, University of Sriwijaya, Palembang
  • Leonard Nainggolan Community-Based Dengue Study, Faculty of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital, Jakarta/Department of Internal Medicine, University of Indonesia, Jakarta
  • Agustin Iskandar Department of Clinical Pathology, Brawijaya University, Malang

DOI:

https://doi.org/10.24293/ijcpml.v30i3.2221

Keywords:

Dengue, plasma leakage marker, HSPG

Abstract

Plasma leakage is a state of increased vascular permeability due to loss of interendothelial junction and focal adhesion. Endothelium glycocalyx plays a major role in the pathogenesis of plasma leakage. Proteoglycans glycocalyx consists of heparan sulfate (HSPG) around 50-90%. Plasma leakage in dengue infection can be fatal and early detection is essential. This study aimed to determine the optimal cut-off value of HSPG levels for early marker of plasma leakage in dengue infection. The study was a retrospective cohort study as a part of the Community Based Dengue Study of the Faculty of Medicine, University of Indonesia, which was conducted between February 2010 and January 2011. Subjects were recruited by consecutive sampling. Dengue infection was confirmed by conventional PCR serotyping. Subjects were categorized into 2 groups, i.e. those with and without plasma leakage. Plasma leakage was confirmed by hemoconcentration or hypoalbuminemia or USG results. The level of HSPG was measured using the ELISA method from the first until the third day of the hospital admission. A total of 40 subjects were involved in this study, consisting of 21 with leakage and 19 without leakage. The optimal cut-off level of HSPG as a marker of early plasma leakage in dengue infection patients on the 1st day, 2nd day, and 3rd day was was 2179.73 pg/mL, 2538.66 pg/mL, and 1294.06 pg/mL, respectively. HSPG could as an early marker of plasma leakage in dengue infection with an optimal cut-off value for each of the first 3 days of the patient's fever. A pediatric study was recommended to obtain the optimal cut-off value for HSPG.

Downloads

Download data is not yet available.

References

https://www.kemkes.go.id/id/profil-kesehatan-indonesia-2021

(accessed February 25, 2023).

https://www.ecdc.europa.eu/en/dengue-monthly (accessed February 26, 2023).

Mustafa MS, Rasotgi V, Jain S, Gupta V. Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Med J Armed Forces India, 2015; 71(1): 67-70.

Chaudhry MRF. Dengue virus infection outbreak: Comparison with other viral infection outbreak. In: Qureshi AI, Saeed O, editors. Dengue virus disease: From origin to outbreak. London, Academic Press, 2020; 17-35.

Dewi BE, Nainggolan L, Sudiro TM, Chenderawasi S, Goentoro PL, Sjatha F. Circulation of various dengue serotypes in a Community-Based Study in Jakarta, Indonesia. Jpn. J. Infect. Dis, 2021; 74: 17-22.

Ramadhani MT, Aryati, Arfijanto MV. IgA anti-dengue profile in samples with positive dengue PCR or NS1. Indonesian Journal of Clinical Pathology and Medical Laboratory, 2018; 25(1): 16-20.

Adissadah AF, Aryati, Pusarawati S. Prevalence of expanded dengue syndrome in patients with dengue irus infection at the Dr. Soetomo Hospital Surabaya in 2017-2018. Indonesian Journal of Clinical Pathology and Medical Laboratory, 2020; 26(3): 307-11.

https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue (accessed February 1, 2023).

Bhatt P, Sabeena SP, Varma M, Arunkumar G. Current understanding of the pathogenesis of dengue virus infection. Curr Microbiol, 2021; 78(1):17-32.

Trung DT, Wills B. Clinical features of dengue. 2nd Ed., Oxford, Medawar Pathogen Research, 2014; 115-44.

https://www.who.int/iris/bitstream/handle/10665/204894/B4751.pdf (accessed February 27, 2023).

https://www.iris.paho.org/bitstream/handle/10665.2/55867/9789275124871_eng.pdf (accessed February 27, 2023).

Sigera PS, Weeratunga P, Fernando SD, Desilva NL, Rodrigo C. Rational use of ultrasonography with triaging of patients to detect dengue plasma leakage in resource limited settings: A prospective cohort study. TMIH, 2021; 26(8): 993–1001.

Adil B, Rabbani A, Ahmed S, Arshad I Sr, Khalid MA. Gall bladder wall thickening in dengue fever - aid in labelling dengue hemorrhagic fever and a marker of severity. Cureus, 2020; 12(11): e11331.

Vittum Z, Cocchiaro S, Mensah SA. Basal endothelial glycocalyx's response to shear stress: A review of structure, function, and clinical implications. Front Cell Dev Biol, 2024; 18(12): 1371769.

Dull RO, Hahn RG. The glycocalyx as a permeability barrier: Basic science and clinical evidence. Crit Care, 2022; 26(1): 273.

Wu L, Davies GJ. An overview of the structure, mechanism and specificity of human heparanase. In: Vlodavsky I, Sanderson RD, Ilan N, editors. Heparanase from basic research to clinical applications. Switzerland, Springer Nature, 2020; 139-67.

Vlodavsky I, Ilan N, Sanderson RD. Forty years of basic and translational heparanase research. Adv Exp Med Biol, 2020; 1221: 3-59.

Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto SH. Perkiraan besar sampel. In: Sastroasmoro S, Ismael S, editors. Dasar-dasar metodologi penelitian klinis. 5th Ed., Jakarta, CV Sagung Seto, 2014; 352-87.

Dahlan MS. Besar sampel dalam penelitian kedokteran dan kesehatan. 5th Ed., Jakarta, Salemba Medika, 2019; 235-62.

https//www.who.int/iris/bitstream/handle/10665/41988/9241545003_eng.pdf (accessed February 27, 2023).

Prihatni D, Kosasih A, Parwati I. Rentang nilai normal hematologi penduduk Indonesia dewasa. Jakarta, Perhimpunan Dokter Spesialis Patologi Klinik Indonesia, 2019; 12-3.

Lepedda AJ, Nieddu G, Piperigkou Z, Kyriakopoulou K, Karamanos N, Formato M. Circulating heparan sulfate proteoglycans as biomarkers in health and disease. Semin Thromb Hemost, 2021; 47: 295–307.

Ling J, Li J, Khan A, Lundkvist A, Ping Li J. Is heparan sulfate a target for inhibition of RNA virus infection? Am J Physiol Cell Physiol, 2022; 322: 605–13.

Koganti R, Memon A, Shukla D. Emerging roles of heparan sulfate proteoglycans in viral pathogenesis. Semin Thromb Hemost, 2021; 47(3): 283-94.

Moore KH, Murphy HA, George EM. The glycocalyx: A central regulator of vascular function. Am J Physiol Regul Integr Comp Physiol, 2021; 320(4): 508–18.

Tian CX, Baharuddin KA, Farid AWS, Andey R, Ridzuan MI, Azrin AHS. Ultrasound findings of plasma leakage as imaging adjunct in clinical management of dengue fever without warning signs. Med J Malaysia, 2020; 75(6): 635-41.

Downloads

Submitted

2023-07-18

Accepted

2024-04-01

Published

2024-06-06

How to Cite

[1]
Chenderawasi, S., Dharma, R., Pohan, H.T., Dewi, B.E., Setiabudy, R., Suhendro, S., Aryati, A., Darmawan, H., Nainggolan, L. and Iskandar, A. 2024. Cut-off Value of HSPG for Early Marker of Plasma Leakage in Adult Dengue Patient. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 30, 3 (Jun. 2024), 259–264. DOI:https://doi.org/10.24293/ijcpml.v30i3.2221.

Issue

Vol. 30 No. 3 (2024)

Section

Articles

License

Copyright (c) 2024 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.